Deng Liang, Huang Lu, Sun Yong, Heath Jack M, Wu Hui, Chen Yabing
From the Departments of Pathology (L.D., L.H., Y.S., J.M.H., Y.C.) and Pediatric Dentistry (H.W.), University of Alabama at Birmingham and Birmingham Veterans Affairs Medical Center; and Department of Research Service (Y.C.), University of Alabama at Birmingham.
Arterioscler Thromb Vasc Biol. 2015 Jan;35(1):175-83. doi: 10.1161/ATVBAHA.114.304786. Epub 2014 Nov 6.
Vascular calcification is a characteristic feature of atherosclerosis, diabetes mellitus, and end-stage renal disease. We have demonstrated that activation of protein kinase B (AKT) upregulates runt-related transcription factor 2 (Runx2), a key osteogenic transcription factor that is crucial for calcification of vascular smooth muscle cells (VSMC). Using mice with SMC-specific deletion of phosphatase and tensin homolog (PTEN), a major negative regulator of AKT, the present studies uncovered a novel molecular mechanism underlying PTEN/AKT/FOXO (forkhead box O)-mediated Runx2 upregulation and VSMC calcification.
SMC-specific PTEN deletion mice were generated by crossing PTEN floxed mice with SM22α-Cre transgenic mice. The PTEN deletion resulted in sustained activation of AKT that upregulated Runx2 and promoted VSMC calcification in vitro and arterial calcification ex vivo. Runx2 knockdown did not affect proliferation but blocked calcification of the PTEN-deficient VSMC, suggesting that PTEN deletion promotes Runx2-depedent VSMC calcification that is independent of proliferation. At the molecular level, PTEN deficiency increased the amount of Runx2 post-transcriptionally by inhibiting Runx2 ubiquitination. AKT activation increased phosphorylation of FOXO1/3 that led to nuclear exclusion of FOXO1/3. FOXO1/3 knockdown in VSMC phenocopied the PTEN deficiency, demonstrating a novel function of FOXO1/3, as a downstream signaling of PTEN/AKT, in regulating Runx2 ubiquitination and VSMC calcification. Using heterozygous SMC-specific PTEN-deficient mice and atherogenic ApoE(-/-) mice, we further demonstrated AKT activation, FOXO phosphorylation, and Runx2 ubiquitination in vascular calcification in vivo.
Our studies have determined a new causative effect of SMC-specific PTEN deficiency on vascular calcification and demonstrated that FOXO1/3 plays a crucial role in PTEN/AKT-modulated Runx2 ubiquitination and VSMC calcification.
血管钙化是动脉粥样硬化、糖尿病和终末期肾病的一个特征性表现。我们已经证明,蛋白激酶B(AKT)的激活会上调与矮小相关的转录因子2(Runx2),这是一种关键的成骨转录因子,对血管平滑肌细胞(VSMC)的钙化至关重要。通过使用平滑肌细胞特异性缺失磷酸酶和张力蛋白同源物(PTEN)(AKT的一种主要负调节因子)的小鼠,本研究揭示了PTEN/AKT/FOXO(叉头框O)介导的Runx2上调和VSMC钙化的一种新分子机制。
通过将PTEN基因敲除小鼠与SM22α-Cre转基因小鼠杂交,构建了平滑肌细胞特异性PTEN缺失小鼠。PTEN的缺失导致AKT持续激活,从而上调Runx2,并在体外促进VSMC钙化,在体内促进动脉钙化。Runx2基因敲低不影响增殖,但可阻断PTEN缺陷型VSMC的钙化,这表明PTEN缺失促进了依赖Runx2的VSMC钙化,且该钙化与增殖无关。在分子水平上,PTEN缺陷通过抑制Runx2泛素化在转录后增加了Runx2的量。AKT激活增加了FOXO1/3的磷酸化,导致FOXO1/3从细胞核中排出。VSMC中FOXO1/3基因敲低模拟了PTEN缺陷,证明了FOXO1/3作为PTEN/AKT的下游信号,在调节Runx2泛素化和VSMC钙化方面具有新功能。使用杂合的平滑肌细胞特异性PTEN缺陷小鼠和致动脉粥样硬化的ApoE(-/-)小鼠,我们进一步证明了体内血管钙化过程中的AKT激活、FOXO磷酸化和Runx2泛素化。
我们的研究确定了平滑肌细胞特异性PTEN缺陷对血管钙化的新致病作用,并证明FOXO1/3在PTEN/AKT调节的Runx2泛素化和VSMC钙化中起关键作用。